Our Products and Offerings
Our Science, Your Health
With a footprint across 100+ countries and all major therapy areas, Nexa Pharma is the world’s 10th largest generic pharma company. Our unrelenting focus on responsible manufacturing drives our sustained growth as a global formulations and API major. Our 15 state-of-the-art manufacturing facilities spread across India, the US, Brazil and Mexico are benchmarked to international standards, and play a critical role in helping us deliver affordable and quality healthcare.
We follow the science, and are driven by research and innovation to develop a wide range of products in both branded and generic formulations, biotech products, Active Pharmaceutical Ingredients (API) and speciality drugs to address evolving patient needs.
Key Therapeutic Areas
Over the past six decades, Nexa Pharma has carved a niche in numerous therapy areas. Today, we are the global leader in the Anti-Tuberculosis segment and continue to strengthen our anti-TB portfolio with the development of products for treating multi-drug resistant (MDR) tuberculosis. We are also among the leading pharmaceutical companies across geographies in diabetes, cardiology, respiratory and ophthalmology, among others, pioneering best-in-class treatment protocols in these areas.
Active Pharmaceutical Ingredients (APIs)
Nexa Pharma is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and a key supplier to global bodies and governments in more than 70 countries. Superior chemistry skills, a commitment to quality and cost-effective manufacturing are hallmarks of our API capabilities. Our proficiency in API manufacturing also enables us to stay backward integrated with our formulations production and ensure a stable supply chain to meet stringent customer requirements, making us one of the most reliable API partners globally.